This three-part course is designed to review arrhythmia mechanisms and mapping/ablation strategies in patients with SVT, atrial fibrillation/flutter, and ventricular arrhythmias for the EP professional.These sessions were presented as part of the Allied Professionals Forum at HRS Scientific Sessions 2019. The Allied Professional Forum promotes quality education and inspire attendees to expand scientific discovery to apply it to their daily practice.For information on registering for the 2020 Allied Professionals Forum and other sessions at #HRS2020, please click here.
Arrhythmia Mechanisms and EGM InterpretationUnderstanding Our History: The Rapid Evolution of Electrophysiology from Mechanistic Investigation to Major Clinical TherapiesMelvin M. Scheinman, MD, FHRS, Univ of California-San Francisco, Cardiac EP, San Francisco, CABurn It In Your Brain!" - Key ECG Patterns that Help Discern Arrhythmia Mechanisms and Anatomical Relationships"Scott J. Cox, MS, PAC, CEPS, CCDS, Main Line Health System, Newtown, PAThe Diagnostic EP Study - Initial EGM Interpretation and Conduction System CharacterizationJonathan W. Waks, MD, Beth Israel Deaconess Medical Center, Chestnut Hill, MAInduction of Sustained Tachycardia During EPS: Step-wise Approach for Identifying the Differential DiagnosesSamir F. Saba, MD, FHRS, Univ of Pittsburgh Medical Cen, Pittsburgh, PACatheter Ablation of Atrial ArrhythmiasAF Ablation in 2019 and Beyond: Review of Current Strategies and Promising Future Directions
Kirstan Clay-Weinfeld, BSN, MSN, ACNP, CCRN, Penn Medicine - Pennsylvania H, Wilmington, DECollateral Damage During AF Ablation: How Do we Minimize Risk and Maximize Therapeutic Benefit?Erin E. Flatley, BSN, MSN, NP, University of California San Francisco, San Francisco, CA Reversing AF Disease by Lifestyle Management: Current Role and Potential Implications for Timing and Recommendation of AF AblationMelissa E. Middeldorp, Centre for Heart Rhythm Disorders, Norwood, Australia Catheter Ablation of Ventricular ArrhythmiasEvolution of VT Ablation - What Have We Learned and Where Are We Going?Cory M. Tschabrunn, PhD, CEPS, University of Pennsylvania, Philadelphia, PAVT Ablation Pre-procedure Planning: Role of Imaging, Hemodynamic Support, and Special ConsiderationsErica S. Zado, PAC, FHRS, Hospital of the Univ of Pennsylvania, EP, Philadelphia, PA
Approaching Current Challenges in VT Mapping and Ablation: Lesion Enhancement TechniquesJonathan W. Waks, MD, Beth Israel Deaconess Medical Center, Chestnut Hill, MAInduction of Sustained Tachycardia During EPS: Step-wise Approach for Identifying the Differential DiagnosesWendy S. Tzou, MD, FHRS, University of Colorado Denver, Aurora, CO
To review arrhythmia mechanisms and cardiac anatomy for the EP professionalTo review SVT arrhythmia differentiation in the EP labTo review fundamentals of AF and VT ablation procedures
A CME Certificate (for physicians) or Certificate of Participation (for non-physicians) will be provided to individuals seeking credit from the following organizations which accept AMA PRA Category 1 Credit(s)™ or have identified credit awarded by ACCME accredited providers as being “substantially equivalent” to their own. Note that participants are advised to contact their certifying body for specific information regarding credit submissions:
· American Academy of Family Practice (AAFP) for elective credit
· American Academy of Nurse Practitioners Certification Board (AANPCB)
· American Academy of Physician Assistants (AAPA)
· American Nurses Credentialing Center (ANCC)
· American Osteopathic Association (AOA) for Category 2 credit
· Committee on Accreditation of Continuing Medical Education (Canada)
· European Board of Accreditation in Cardiology (EBAC)
· European CME Credits (ECMEC)
· German Chambers of Physicians
· Oman Medical Specialty Board
· Qatar Council for Health Practitioners
· Royal College of Physicians and Surgeons of Canada
DISCLOSURE POLICYThe Heart Rhythm Society is committed to the provision of Continuing Medical Education (CME) that is balanced, objective, and evidence-based. The Heart Rhythm Society adheres to the Standards for Commercial Support (SCS) of the Accreditation Council for Continuing Medical Education (ACCME) which requires that those individuals in a position to control the content of an educational activity (including planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all relevant financial relationships (for self and for spouse/partner) with an ACCME-defined commercial interest within the 12 months prior to the disclosure.
VALIDATION
Heart Rhythm Society takes steps to assure its learners and the public that the content of certified activities is accurate and reliable. The following principles are applied to the process of validating CME content. The content is peer-reviewed to ensure the following:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn up to 4.0 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
C.M. Tschabrunn: Research (Contracted Grants for PIs and Named Investigators only) - Biosense Webster, Inc.; Attune Medical.A.J. Cambridge: Nothing relevant to disclose.M.M. Scheinman: Nothing relevant to disclose.E.E. Flatley: Nothing relevant to disclose.K. Clay-Weinfeld: Nothing relevant to disclose.M.E. Middeldorp: Nothing relevant to disclose.E.S. Zado: Nothing relevant to disclose.W.S. Tzou: Honoraria/Speaking/Consulting Fee - Biosense Webster, Inc.; Abbott Laboratories; Boston Scientific; Medtronic, Inc.; Biotronik.M.E. Middeldorp: Nothing relevant to disclose.S.J. Cox: Honoraria/Speaking/Consulting Fee - ScottCare Inc,; Abbott Laboratories.J.W. Waks: Payment for Clinical Endpoint Committee - Baim Clinical Research Institute.S.F. Saba: Honoraria/Speaking/Consulting Fee - Boston Scientific. Research (Contracted Grants for PIs and Named Investigators only) - Boston Scientific; Medtronic, Inc